Compare TRST & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRST | BIOA |
|---|---|---|
| Founded | 1902 | 2015 |
| Country | United States | United States |
| Employees | N/A | 62 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 782.5M | 776.6M |
| IPO Year | 1994 | N/A |
| Metric | TRST | BIOA |
|---|---|---|
| Price | $46.17 | $16.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $51.50 |
| AVG Volume (30 Days) | 96.4K | ★ 414.5K |
| Earning Date | 04-21-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.26% | N/A |
| EPS Growth | ★ 26.46 | N/A |
| EPS | ★ 3.25 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $846.41 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $14.35 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.10 | $3.66 |
| 52 Week High | $48.45 | $24.00 |
| Indicator | TRST | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 61.31 | 43.72 |
| Support Level | $41.96 | $15.47 |
| Resistance Level | $46.89 | $18.65 |
| Average True Range (ATR) | 0.91 | 1.08 |
| MACD | 0.30 | -0.01 |
| Stochastic Oscillator | 77.47 | 41.20 |
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.